Hill Malcolm R 4
4 · Evoke Pharma Inc · Filed Apr 28, 2022
Insider Transaction Report
Form 4
Evoke Pharma IncEVOK
Hill Malcolm R
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-04-27+57,750→ 57,750 totalExercise: $0.66Exp: 2032-04-26→ Common Stock (57,750 underlying)
Footnotes (1)
- [F1]The total number of shares of common stock subject to the option vests on the one-year anniversary of the date of grant, subject to the reporting person's continued service to the Issuer through such vesting date.